325 related articles for article (PubMed ID: 6934851)
1. Sequential combination of methotrexate and L-asparaginase in the treatment of refractory acute leukemia.
Amadori S; Tribalto M; Pacilli L; De Laurentis C; Papa G; Mandelli F
Cancer Treat Rep; 1980; 64(8-9):939-42. PubMed ID: 6934851
[TBL] [Abstract][Full Text] [Related]
2. Asparaginase and methotrexate combination chemotherapy in relapsed acute lymphoblastic leukemia in adults.
Yap BS; McCredie KB; Keating MJ; Bodey GP; Freireich EJ
Cancer Treat Rep; 1981; 65 Suppl 1():83-7. PubMed ID: 6948610
[TBL] [Abstract][Full Text] [Related]
3. Preliminary results of the combination methotrexate-asparaginase in patients with acute non lymphoid leukemia.
Mandelli F; Amadori S; Pacilli L; Tribalto M
Biomedicine; 1978 Jun; 29(4):116-7. PubMed ID: 687752
[TBL] [Abstract][Full Text] [Related]
4. Phase II study with sequential L-asparaginase and methotrexate in advanced refractory breast cancer.
Yap HY; Benjamin RS; Blumenschein GR; Hortobagyi GN; Tashima CK; Buzdar AU; Bodey GP
Cancer Treat Rep; 1979 Jan; 63(1):77-83. PubMed ID: 369695
[TBL] [Abstract][Full Text] [Related]
5. Asparaginase-methotrexate in combination chemotherapy: schedule-dependent differential effects on normal versus neoplastic cells.
Capizzi RL
Cancer Treat Rep; 1981; 65 Suppl 4():115-21. PubMed ID: 7049375
[TBL] [Abstract][Full Text] [Related]
6. Refractory acute leukaemia in adults treated with sequential colaspase and high-dose methotrexate.
Yap BS; McCredie KB; Benjamin RS; Bodey GP; Freireich EJ
Br Med J; 1978 Sep; 2(6140):791-3. PubMed ID: 279387
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
Lange BJ; Blatt J; Sather HN; Meadows AT
Med Pediatr Oncol; 1996 Jul; 27(1):15-20. PubMed ID: 8614385
[TBL] [Abstract][Full Text] [Related]
8. Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia: a report from Childrens Cancer Study Group.
Ertel IJ; Nesbit ME; Hammond D; Weiner J; Sather H
Cancer Res; 1979 Oct; 39(10):3893-6. PubMed ID: 383278
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate and asparaginase combination chemotherapy in refractory acute lymphoblastic leukemia of childhood.
Lobel JS; O'Brien RT; McIntosh S; Aspnes GT; Capizzi RL
Cancer; 1979 Mar; 43(3):1089-94. PubMed ID: 284840
[TBL] [Abstract][Full Text] [Related]
10. L-Asparaginase as a single agent in acute lymphocytic leukemia: survey of studies form Childrens Cancer Study Group.
Nesbit ME; Ertel I; Hammond GD
Cancer Treat Rep; 1981; 65 Suppl 4():101-7. PubMed ID: 7049373
[TBL] [Abstract][Full Text] [Related]
11. [Complete remission obtained in refractory acute lymphocytic leukemia using high-dose cytosine arabinoside combined with low-dose L-asparaginase].
Inagaki C; Ito K; Omori I; Shimazaki C; Nishio A; Haruyama H; Isemura T; Nakagawa M; Ijichi H
Gan To Kagaku Ryoho; 1985 Feb; 12(2):379-82. PubMed ID: 3855616
[TBL] [Abstract][Full Text] [Related]
12. [Sequential combination of high-dose cytosine arabinoside and L-asparaginase in the treatment of refractory acute leukemia and malignant lymphoma].
Shimazaki C; Fujita N; Nakanishi S; Nishio A; Haruyama H; Nakagawa M; Ijichi H
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2202-7. PubMed ID: 3864396
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate/L-asparaginase combination chemotherapy for patients with acute leukemia in relapse: a study of 36 children.
Harris RE; McCallister JA; Provisor DS; Weetman RM; Baehner RL
Cancer; 1980 Nov; 46(9):2004-8. PubMed ID: 6968621
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate plus L-asparaginase. An active combination for children with acute nonlymphocytic leukemia.
Hudson MM; Dahl GV; Kalwinsky DK; Pui CH
Cancer; 1990 Jun; 65(12):2615-8. PubMed ID: 2340462
[TBL] [Abstract][Full Text] [Related]
15. Intermediate dose methotrexate and sequential L-asparaginase for treatment of refractory acute lymphocytic leukaemia.
Shetty PA; Kurkure PA; Dasgupta A
Indian J Cancer; 1984; 21(1):45-9. PubMed ID: 6595214
[No Abstract] [Full Text] [Related]
16. [A case of refractory acute lymphocytic leukemia who achieved a complete remission by mitoxantrone].
Yoshikawa H; Sao H; Tahara T; Akao Y; Yoshikawa S
Gan To Kagaku Ryoho; 1984 Mar; 11(3):515-20. PubMed ID: 6584088
[TBL] [Abstract][Full Text] [Related]
17. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.
Ortega JA; Nesbit ME; Donaldson MH; Hittle RE; Weiner J; Karon M; Hammond D
Cancer Res; 1977 Feb; 37(2):535-40. PubMed ID: 264412
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of a case of childhood acute non-lymphocytic leukemia (ANLL) using high-dose cytosine arabinoside for intensification of early therapy].
Imashuku S; Nakajima T; Morimoto S; Hibi S; Todo S; Morioka Y; Sugimoto T
Gan To Kagaku Ryoho; 1987 Feb; 14(2):527-30. PubMed ID: 3813580
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
Early AP; Preisler HD; Slocum H; Rustum YM
Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
[TBL] [Abstract][Full Text] [Related]
20. [High-dose treatment].
Takaku F
Gan To Kagaku Ryoho; 1985 Apr; 12(4):830-8. PubMed ID: 3872631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]